
NMR · NYSE
The supplied evidence identifies Nomura Holdings Inc as the issuer of the NMR American Depositary Shares and reports FY2026 revenue of $1,204.2 billion, up from $1,068.7 billion in FY2025. It does not specify what products or services Nomura sells, how revenue is divided among operating segments, who its customers are, or the company’s employee, asset or geographic scale. Reported net income is shown as NaNB for both fiscal years, so profitability and earnings mix cannot be described reliably from the supplied information. The available evidence therefore supports only a revenue-based description of the listed holding company.
NMR rose 5.97% over the supplied week, advancing from $9.72 to $10.30. The stock climbed in every reported session, moving to $9.76, $9.91, $10.05, $10.12 and finally $10.30, with no material within-week reversal. Trading volume was broadly steady, ranging from 421,192 to 708,617 shares, and was highest on the penultimate session rather than at the final high. The supplied evidence identifies no company-specific announcement, earnings development or analyst action that explains the advance. It also provides no broader market or sector context, so the move is best characterized as a steady price increase without an evidenced catalyst.
Nomura (NMR) Q1 2027 Earnings Call Transcript
NMR or JPM: Which Is the Better Value Stock Right Now?
MarketAxess Stock Soars 30% on $6 Billion ICE Buyout Deal
Nomura (NMR) Is a Great Choice for 'Trend' Investors, Here's WhyBest Momentum Stock to Buy for July 30thBest Value Stocks to Buy for July 30thNomura Q1 Earnings Call Highlights